The method could be used to develop a blood test to identify inflammatory-bowel-disease patients most at risk.

An experimental blood test can effectively and accurately detect colon cancer in middle-aged folks and seniors, a new study says. The research is published in the Journal of Clinical Oncology.

A new DNA test developed in the UK can accurately predict whether high-risk patients will develop colorectal cancer in the five years. People with inflammatory bowel disease (IBD) — which includes conditions like ulcerative colitis and Crohn’s — are up to four times more likely to get this type of cancer,